PortfoliosLab logoPortfoliosLab logo
INNV vs. MIRM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INNV vs. MIRM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in InnovAge Holding Corp. (INNV) and Mirum Pharmaceuticals, Inc. (MIRM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INNV achieves a 118.88% return, which is significantly higher than MIRM's 34.13% return.


INNV

1D
-2.07%
1M
-5.25%
6M
104.68%
YTD
118.88%
1Y
262.94%
3Y*
18.02%
5Y*
-7.59%
10Y*
ALL TIME*
-12.92%

MIRM

1D
-5.90%
1M
-15.64%
6M
2.64%
YTD
34.13%
1Y
103.67%
3Y*
61.89%
5Y*
48.95%
10Y*
ALL TIME*
34.74%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$2.95M$3.34M$3.45M
$68.27M$72.48M$108.55M

INNV vs. MIRM - Yearly Performance Comparison


2026 (YTD)20252024202320222021
INNV
InnovAge Holding Corp.
118.88%32.06%-34.50%-16.43%43.60%-79.17%
MIRM
Mirum Pharmaceuticals, Inc.
34.13%91.03%40.07%51.38%22.26%-10.89%

Correlation

The correlation between INNV and MIRM is 0.13, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.13

Correlation (3Y)
Balances recent behavior with more history.

0.17

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.13

Correlation (All Time)
Calculated using the full available price history since Mar 4, 2021

0.15

Fundamentals

Market Cap

INNV:

$1.54B

MIRM:

$6.46B

EPS

INNV:

-$0.16

MIRM:

-$14.43

PS Ratio

INNV:

1.63

MIRM:

14.31

PB Ratio

INNV:

6.62

MIRM:

25.71

Total Revenue (TTM)

INNV:

$945.90M

MIRM:

$409.73M

Gross Profit (TTM)

INNV:

$140.05M

MIRM:

-$422.68M

EBITDA (TTM)

INNV:

$5.26M

MIRM:

-$771.51M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INNV vs. MIRM — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

INNV
INNV Risk / Return Rank: 9696
Overall Rank
INNV Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
INNV Sortino Ratio Rank: 9595
Sortino Ratio Rank
INNV Omega Ratio Rank: 9393
Omega Ratio Rank
INNV Calmar Ratio Rank: 9898
Calmar Ratio Rank
INNV Martin Ratio Rank: 9696
Martin Ratio Rank

MIRM
MIRM Risk / Return Rank: 9292
Overall Rank
MIRM Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
MIRM Sortino Ratio Rank: 9090
Sortino Ratio Rank
MIRM Omega Ratio Rank: 9191
Omega Ratio Rank
MIRM Calmar Ratio Rank: 9595
Calmar Ratio Rank
MIRM Martin Ratio Rank: 9292
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

INNV vs. MIRM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for InnovAge Holding Corp. (INNV) and Mirum Pharmaceuticals, Inc. (MIRM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


INNVMIRMDifference
Sharpe ratioReturn per unit of total volatility

+0.69

Sortino ratioReturn per unit of downside risk

+0.73

Omega ratioGain probability vs. loss probability

1.42

1.37

+0.05

Calmar ratioReturn relative to maximum drawdown

7.34

5.14

+2.20

Martin ratioReturn relative to average drawdown

15.83

11.27

+4.56

INNV vs. MIRM - Sharpe Ratio Comparison

The current INNV Sharpe Ratio is 2.96, which is higher than the MIRM Sharpe Ratio of 2.27. The chart below compares the historical Sharpe Ratios of INNV and MIRM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

INNV vs. MIRM - Drawdown Comparison

The maximum INNV drawdown since its inception was -89.92%, which is greater than MIRM's maximum drawdown of -63.78%. Use the drawdown chart below to compare losses from any high point for INNV and MIRM.


Loading charts...

Drawdown Indicators


INNVMIRMDifference

Max Drawdown

Largest peak-to-trough decline

-89.92%

-63.78%

-26.14%

Max Drawdown (1Y)

Largest decline over 1 year

-33.21%

-20.55%

-12.66%

Max Drawdown (3Y)

Largest decline over 3 years

-65.42%

-32.52%

-32.90%

Max Drawdown (5Y)

Largest decline over 5 years

-84.76%

-40.25%

-44.51%

Current Drawdown

Current decline from peak

-56.37%

-17.59%

-38.78%

Average Drawdown

Average peak-to-trough decline

-71.97%

-19.97%

-52.00%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.37%

9.35%

+6.02%

Volatility

INNV vs. MIRM - Volatility Comparison

InnovAge Holding Corp. (INNV) and Mirum Pharmaceuticals, Inc. (MIRM) have volatilities of 13.88% and 13.55%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INNVMIRMDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.88%

13.55%

+0.33%

Volatility (6M)

Calculated over the trailing 6-month period

51.14%

36.27%

+14.87%

Volatility (1Y)

Calculated over the trailing 1-year period

82.81%

46.62%

+36.19%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

74.83%

51.81%

+23.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

72.87%

73.58%

-0.71%

Dividends

INNV vs. MIRM - Dividend Comparison

Neither INNV nor MIRM has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

INNV vs. MIRM - Financials Comparison

This section allows you to compare key financial metrics between InnovAge Holding Corp. and Mirum Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


INNV and MIRM have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INNV has higher volatility (13.88%) compared to MIRM (13.55%). In terms of maximum drawdown, INNV dropped -89.92% vs MIRM's -63.78%.

INNV currently has the higher Sharpe Ratio (2.96 vs 2.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INNV and MIRM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer